Mie University Hospital
In research, Mie University Hospital stands highest in Medicine (#4,982 of 10,443 worldwide) and Health Sciences (#6,621 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 7.7× its share of world research.
- World rank, 2022–2025
- #14,670 of 28,054 · #17,925 all time
- Rank in Japan
- #386 of 1,070
- Research works
- 1.1k ▲ 29% vs 2013–17
- Citations
- 12k 11.3 per fractional work
- Top-10% rate
- 9.1% record average 16.5%
- Open access
- 56% world 28%
What is Mie University Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,982 of 10,443 | 8.9% | 218 | #5702 | |
| Health SciencesDomain | #6,621 of 11,982 | 8.7% | 226 | #7394 |
Each strip is that field’s whole ranked pool, with the notch where Mie University Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Mie University Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 7.7× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 32.8 works7.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.3×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 6.3×
- Medicine 4.1×
- Immunology and Microbiology 1.8×
- Mathematics 1.5×
- Veterinary 1.3×
- Biochemistry, Genetics and Molecular Biology 0.9×
- Health Professions 0.8×
- Dentistry 0.7×
- Chemical Engineering 0.7×
- Nursing 0.7×
- Neuroscience 0.4×
- Engineering 0.2×
- Computer Science 0.2×
- Physics and Astronomy 0.2×
- Psychology 0.1×
- Chemistry 0.1×
- Environmental Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Materials Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Decision Sciences 0.0×
- Social Sciences 0.0×
Who are the top researchers at Mie University Hospital?
Ranked on the composite score, Noriyuki Kato, Kyosuke Tanaka and Michio Kojima lead among researchers whose main affiliation is Mie University Hospital.
- 1 Noriyuki Kato Japan · #362,774 worldwide 101 citations · 45 works
- 2 Kyosuke Tanaka Japan · #457,792 worldwide 73 citations · 27 works
- 3 Michio Kojima Japan · #635,607 worldwide 68 citations · 39 works
- 4 Kei Suzuki Japan · #763,943 worldwide 32 citations · 31 works
- 5 Masafumi Takafuji Japan · #820,898 worldwide 24 citations · 17 works
- 6 Akiko Nakamura Japan · #939,677 worldwide 67 citations · 54 works
- 7 Toru Ogura Japan · #944,499 worldwide 91 citations · 38 works
- 8 Yoshiki Yamashita Japan · #1,036,226 worldwide 47 citations · 49 works
- 9 Yasuhiko Hamada Japan · #1,048,311 worldwide 10 citations · 24 works
- 10 Akinori Takada Japan · #1,110,616 worldwide 8 citations · 15 works
Which keywords describe research at Mie University Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Clinical Practice Guidelines, Endoscopic Resection, Magnetic Resonance Imaging, Prognostic Factors, Survival Analysis and Surgical Management.
- Imatinib Mesylate
- Echocardiography
- Preoperative Chemoradiotherapy
- Computed Tomography Angiography
- PET Imaging
- Metastatic Gastric Cancer
- Genetic Mutations
- Neoadjuvant Chemotherapy
- Guidelines
- Gastric Cancer
- Immunotherapy
- Radiation Exposure
- Molecular Characterization
- Surgical Management
- Clinical Trials
- Prognostic Factors
- Magnetic Resonance Imaging
- Endoscopic Resection
- Clinical Practice Guidelines
- Chemotherapy
- Epidemiology
- Inflammation
- Treatment
- Diagnosis
- Cancer
- Survival Analysis
- Biomarkers
- Neoadjuvant Therapy
- Surgery
- Coronary Artery Disease
- Adjuvant Therapy
- Myocardial Infarction
- Heart Failure
- Cardiac Imaging
- Lymph Node Dissection
- Prognosis
- Metastasis
- Myocardial Perfusion
- Chemoradiation
- Breast Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology32▲ 2.9×66 topics
- Chemotherapy18▲ 9.4×19 topics
- Inflammation15▲ 2.7×40 topics
- Clinical Practice Guidelines15▲ 9.9×13 topics
- Treatment13▲ 3.9×26 topics
- Endoscopic Resection12▲ 43×2 topics
- Diagnosis12▲ 4.5×24 topics
- Magnetic Resonance Imaging11▲ 16×7 topics
- Cancer11▲ 2.8×24 topics
- Prognostic Factors10▲ 8.6×13 topics
- Survival Analysis10▲ 13×6 topics
- Clinical Trials10▲ 5.4×15 topics
- Biomarkers10▲ 5.0×11 topics
- Surgical Management10▲ 8.4×12 topics
- Neoadjuvant Therapy9▲ 14×5 topics
- Molecular Characterization9▲ 18×5 topics
- Surgery8▲ 8.6×9 topics
- Radiation Exposure8▲ 29×2 topics
- Coronary Artery Disease8▲ 25×2 topics
- Immunotherapy8▲ 4.0×13 topics
- Adjuvant Therapy8▲ 22×2 topics
- Gastric Cancer8▲ 24×3 topics
- Myocardial Infarction8▲ 12×5 topics
- Guidelines8▲ 5.8×12 topics
- Heart Failure7▲ 5.9×11 topics
- Neoadjuvant Chemotherapy7▲ 30×2 topics
- Cardiac Imaging7▲ 21×3 topics
- Genetic Mutations7▲ 5.7×16 topics
- Lymph Node Dissection7▲ 41×1 topic
- Metastatic Gastric Cancer7▲ 41×1 topic
- Prognosis7▲ 7.3×7 topics
- PET Imaging6▲ 14×4 topics
- Metastasis6▲ 6.7×9 topics
- Computed Tomography Angiography6▲ 34×1 topic
- Myocardial Perfusion6▲ 34×1 topic
- Preoperative Chemoradiotherapy6▲ 28×2 topics
- Chemoradiation6▲ 33×2 topics
- Echocardiography6▲ 7.7×7 topics
- Breast Cancer6▲ 8.4×7 topics
- Imatinib Mesylate6▲ 39×2 topics
Which research topics does Mie University Hospital publish most on?
By volume in 2022–2025: Gastric Cancer Management and Outcomes, Cardiac Imaging and Diagnostics, Esophageal Cancer Research and Treatment and Gastrointestinal Tumor Research and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 7 works
- 2 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 6 works
- 3 Esophageal Cancer Research and Treatment Surgery 5 works
- 4 Gastrointestinal Tumor Research and Treatment Gastroenterology 5 works
- 5 Esophageal and GI Pathology Surgery 4 works
- 6 Advanced X-ray and CT Imaging Biomedical Engineering 3 works
- 7 Advanced MRI Techniques and Applications Radiology, Nuclear Medicine and Imaging 3 works
- 8 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 3 works
- 9 Metastasis and carcinoma case studies Pulmonary and Respiratory Medicine 2 works
- 10 Gastrointestinal disorders and treatments Surgery 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Mie University Hospital's research output changed?
Output in 2018–2022 was 29% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tsu
- Mie University
- Mie Chuo Medical Center
- Mie Prefectural College Of Nursing
- National Mie Hospital
- Tsu City College
- Mie Chukyo University
- Mie Prefectural Education Center
- Takada Junior College
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.